FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383710879> ?p ?o ?g. }

• W4383710879 endingPage "e2322505" @default.
• W4383710879 startingPage "e2322505" @default.
• W4383710879 abstract "Importance Older patients using many prescription drugs (hyperpolypharmacy) may be at increased risk of adverse drug effects. Objective To test the effectiveness and safety of a quality intervention intended to reduce hyperpolypharmacy. Design, Setting, and Participants This randomized clinical trial allocated patients 76 years or older who used 10 or more prescription medications to a deprescribing intervention or to usual care (1:1 ratio) at an integrated health system with multiple preexisting deprescribing workflows. Data were collected from October 15, 2020, to July 29, 2022. Intervention Physician-pharmacist collaborative drug therapy management, standard-of-care practice recommendations, shared decision-making, and deprescribing protocols administered by telephone over multiple cycles for a maximum of 180 days after allocation. Main Outcomes and Measures Primary end points were change in the number of medications and in the prevalence of geriatric syndrome (falls, cognition, urinary incontinence, and pain) from 181 to 365 days after allocation compared with before randomization. Secondary outcomes were use of medical services and adverse drug withdrawal effects. Results Of a random sample of 2860 patients selected for potential enrollment, 2470 (86.4%) remained eligible after physician authorization, with 1237 randomized to the intervention and 1233 to usual care. A total of 1062 intervention patients (85.9%) were reached and agreed to enroll. Demographic variables were balanced. The median age of the 2470 patients was 80 (range, 76-104) years, and 1273 (51.5%) were women. In terms of race and ethnicity, 185 patients (7.5%) were African American, 234 (9.5%) were Asian or Pacific Islander, 220 (8.9%) were Hispanic, 1574 (63.7%) were White (63.7%), and 257 (10.4%) were of other (including American Indian or Alaska Native, Native Hawaiian, or &amp;gt;1 race or ethnicity) or unknown race or ethnicity. During follow-up, both the intervention and usual care groups had slight reductions in the number of medications dispensed (mean changes, −0.4 [95% CI, −0.6 to −0.2] and −0.4 [95% CI, −0.6 to −0.3], respectively), with no difference between the groups ( P = .71). There were no significant changes in the prevalence of a geriatric condition in the usual care and intervention groups at the end of follow-up and no difference between the groups (baseline prevalence: 47.7% [95% CI, 44.9%-50.5%] vs 42.9% [95% CI, 40.1%-45.7%], respectively; difference-in-differences, 1.0 [95% CI, −3.5 to 5.6]; P = .65). No differences in use of medical services or adverse drug withdrawal effects were observed. Conclusions and Relevance In this randomized clinical trial from an integrated care setting with various preexisting deprescribing workflows, a bundled hyperpolypharmacy deprescribing intervention was not associated with reduction in medication dispensing, prevalence of geriatric syndrome, utilization of medical services, or adverse drug withdrawal effects. Additional research is needed in less integrated settings and in more targeted populations. Trial Registration ClinicalTrials.gov Identifier: NCT05616689" @default.
• W4383710879 created "2023-07-11" @default.
• W4383710879 creator A5000351033 @default.
• W4383710879 creator A5000985141 @default.
• W4383710879 creator A5007864412 @default.
• W4383710879 creator A5016319219 @default.
• W4383710879 creator A5017575012 @default.
• W4383710879 creator A5017728402 @default.
• W4383710879 creator A5025397179 @default.
• W4383710879 creator A5026750788 @default.
• W4383710879 creator A5029926598 @default.
• W4383710879 creator A5038141304 @default.
• W4383710879 creator A5040173544 @default.
• W4383710879 creator A5041228128 @default.
• W4383710879 creator A5054869745 @default.
• W4383710879 date "2023-07-10" @default.
• W4383710879 modified "2023-09-25" @default.
• W4383710879 title "Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults" @default.
• W4383710879 cites W1594676157 @default.
• W4383710879 cites W1867169352 @default.
• W4383710879 cites W1984458266 @default.
• W4383710879 cites W2019687020 @default.
• W4383710879 cites W2052575233 @default.
• W4383710879 cites W2059707463 @default.
• W4383710879 cites W2097206036 @default.
• W4383710879 cites W2103440699 @default.
• W4383710879 cites W2120032954 @default.
• W4383710879 cites W2123208652 @default.
• W4383710879 cites W2131914658 @default.
• W4383710879 cites W2133346238 @default.
• W4383710879 cites W2153054970 @default.
• W4383710879 cites W2165724006 @default.
• W4383710879 cites W2288614434 @default.
• W4383710879 cites W2334148135 @default.
• W4383710879 cites W2465454303 @default.
• W4383710879 cites W2508271679 @default.
• W4383710879 cites W2561359674 @default.
• W4383710879 cites W2570117592 @default.
• W4383710879 cites W2746811564 @default.
• W4383710879 cites W2785395993 @default.
• W4383710879 cites W2792418449 @default.
• W4383710879 cites W2884077652 @default.
• W4383710879 cites W2887289383 @default.
• W4383710879 cites W2898238719 @default.
• W4383710879 cites W2914781067 @default.
• W4383710879 cites W2940759308 @default.
• W4383710879 cites W2945729231 @default.
• W4383710879 cites W2981151994 @default.
• W4383710879 cites W3005021111 @default.
• W4383710879 cites W3036625496 @default.
• W4383710879 cites W3080542978 @default.
• W4383710879 cites W3104598692 @default.
• W4383710879 cites W3214891986 @default.
• W4383710879 cites W4206243259 @default.
• W4383710879 cites W4220815995 @default.
• W4383710879 cites W4236186493 @default.
• W4383710879 cites W4241631797 @default.
• W4383710879 cites W4243016422 @default.
• W4383710879 cites W4281700963 @default.
• W4383710879 cites W4295612440 @default.
• W4383710879 cites W4296390655 @default.
• W4383710879 cites W4296976768 @default.
• W4383710879 doi "https://doi.org/10.1001/jamanetworkopen.2023.22505" @default.
• W4383710879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37428504" @default.
• W4383710879 hasPublicationYear "2023" @default.
• W4383710879 type Work @default.
• W4383710879 citedByCount "0" @default.
• W4383710879 crossrefType "journal-article" @default.
• W4383710879 hasAuthorship W4383710879A5000351033 @default.
• W4383710879 hasAuthorship W4383710879A5000985141 @default.
• W4383710879 hasAuthorship W4383710879A5007864412 @default.
• W4383710879 hasAuthorship W4383710879A5016319219 @default.
• W4383710879 hasAuthorship W4383710879A5017575012 @default.
• W4383710879 hasAuthorship W4383710879A5017728402 @default.
• W4383710879 hasAuthorship W4383710879A5025397179 @default.
• W4383710879 hasAuthorship W4383710879A5026750788 @default.
• W4383710879 hasAuthorship W4383710879A5029926598 @default.
• W4383710879 hasAuthorship W4383710879A5038141304 @default.
• W4383710879 hasAuthorship W4383710879A5040173544 @default.
• W4383710879 hasAuthorship W4383710879A5041228128 @default.
• W4383710879 hasAuthorship W4383710879A5054869745 @default.
• W4383710879 hasBestOaLocation W43837108791 @default.
• W4383710879 hasConcept C104863432 @default.
• W4383710879 hasConcept C126322002 @default.
• W4383710879 hasConcept C159110408 @default.
• W4383710879 hasConcept C168563851 @default.
• W4383710879 hasConcept C177713679 @default.
• W4383710879 hasConcept C1862650 @default.
• W4383710879 hasConcept C197934379 @default.
• W4383710879 hasConcept C2426938 @default.
• W4383710879 hasConcept C2776484012 @default.
• W4383710879 hasConcept C2779457091 @default.
• W4383710879 hasConcept C2780665704 @default.
• W4383710879 hasConcept C36434225 @default.
• W4383710879 hasConcept C512399662 @default.
• W4383710879 hasConcept C71924100 @default.
• W4383710879 hasConceptScore W4383710879C104863432 @default.
• W4383710879 hasConceptScore W4383710879C126322002 @default.

• next